4.5 Review

α2-macroglobulin in late-onset Alzheimer's disease

期刊

EXPERIMENTAL GERONTOLOGY
卷 35, 期 4, 页码 473-479

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0531-5565(00)00113-3

关键词

alpha 2-microglobulin; Alzheimer's disease; beta-amyloid; low density lipoprotein receptor-related protein; polymorphism; protease inhibitor

向作者/读者索取更多资源

alpha 2-macroglobulin (alpha(2)M) is an abundant plasma protein similar in structure and function to a group of proteins called alpha-macroglobulins. alpha(2)M is also produced in the brain where it binds multiple extracellular ligands and is internalized by neurons and astrocytes. In the brain of Alzheimer's disease (AD) patients, alpha(2)M has been localized to diffuse amyloid plaques. alpha(2)M also binds soluble beta-amyloid, of which it mediates degradation. However, an excess of alpha(2)M can also have neurotoxic effects. Based on genetic evidence, is now recognized as one of the two confirmed late onset AD genes. As for the three early onset genes (the amyloid beta-protein precursor and the two presenilins) and for the other late onset gene (ApoE), DNA polymorphisms in the A2M gene associated with AD result in significantly increased accumulation of amyloid plaques in AD brains. These data support an important role for A2M in AD etiopathology. (C) 2000 Published by Elsevier Science Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据